跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,995 条关于
“degrader-antibody conjugates”
全部
13,995
临床试验
5,300
药物
2,725
机构
58
资讯
5,912
3个月前
J&J Acquires Firefly Bio in $1 Billion Deal to Advance Pan-KRAS Degrader-Antibody Conjugates
8个月前
Orum Therapeutics Appoints Chad May as Chief Scientific Officer to Advance Degrader-Antibody Conjugate Platform
11个月前
Orum Therapeutics Strengthens Degrader-Antibody Conjugate Platform with Key Executive Appointment
去年
Nurix Therapeutics Advances BTK Degrader NX-5948 and Reinitiates NX-2127 Trial
5个月前
C4 Therapeutics and Roche Expand Partnership with $1 Billion+ DAC Collaboration
26天前
Orum Therapeutics Announces U.S. FDA Clearance of IND for ORM-1153, a First-in-Class CD123-GSPT1 Degrader-Antibody Conjugate
10个月前
Nurix Therapeutics Strengthens Board with Former Pfizer and Seagen Executive Roger Dansey
2年前
Prelude Therapeutics' PRT3789 Shows Promise in SMARCA4-Mutated Cancers
3个月前
Targeted Protein Degradation: The Next Frontier in Drugging the 'Undruggable'
去年
Baylink Biosciences to Present Novel ADC Platform Data for Cancer Treatment at AACR 2025
第 1 页，共 592 页
上一页
下一页
